Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 1
2017 1
2018 5
2019 2
2020 3
2021 4
2022 2
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer.
Best SA, Gubser PM, Sethumadhavan S, Kersbergen A, Negrón Abril YL, Goldford J, Sellers K, Abeysekera W, Garnham AL, McDonald JA, Weeden CE, Anderson D, Pirman D, Roddy TP, Creek DJ, Kallies A, Kingsbury G, Sutherland KD. Best SA, et al. Cell Metab. 2022 Jun 7;34(6):874-887.e6. doi: 10.1016/j.cmet.2022.04.003. Epub 2022 May 2. Cell Metab. 2022. PMID: 35504291 Free article.
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains.
Moffet JJD, Fatunla OE, Freytag L, Kriel J, Jones JJ, Roberts-Thomson SJ, Pavenko A, Scoville DK, Zhang L, Liang Y, Morokoff AP, Whittle JR, Freytag S, Best SA. Moffet JJD, et al. Among authors: best sa. Neurooncol Adv. 2023 Nov 1;5(1):vdad142. doi: 10.1093/noajnl/vdad142. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38077210 Free PMC article.
Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition.
Kay KE, Lee J, Hong ES, Beilis J, Dayal S, Wesley E, Mitchell S, Wang SZ, Silver DJ, Volovetz J, Johnson S, McGraw M, Grabowski MM, Lu T, Freytag L, Narayana V, Freytag S, Best SA, Whittle JR, Wang Z, Reizes O, Yu JS, Hazen SL, Brown JM, Bayik D, Lathia JD. Kay KE, et al. Among authors: best sa. bioRxiv [Preprint]. 2023 Nov 16:2023.11.14.567048. doi: 10.1101/2023.11.14.567048. bioRxiv. 2023. PMID: 38014234 Free PMC article. Preprint.
"Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.
Best SA, Sutherland KD. Best SA, et al. Cell Cycle. 2018;17(14):1696-1707. doi: 10.1080/15384101.2018.1496756. Epub 2018 Aug 1. Cell Cycle. 2018. PMID: 30009666 Free PMC article. Review.
Editorial: Overcoming drug relapse and therapy resistance in NSCLC.
Parakh S, Leong TL, Best SA, Poh AR. Parakh S, et al. Among authors: best sa. Front Oncol. 2023 Jun 7;13:1230475. doi: 10.3389/fonc.2023.1230475. eCollection 2023. Front Oncol. 2023. PMID: 37350939 Free PMC article. No abstract available.
Characterization of a novel human BFL-1-specific monoclonal antibody.
Gangoda L, Teh CE, Dengler MA, Best SA, Weeden CE, Tai L, Lee EF, Fairlie WD, Sutherland KD, Harrison LC, Gray DH, Strasser A, Herold MJ. Gangoda L, et al. Among authors: best sa. Cell Death Differ. 2020 Feb;27(2):826-828. doi: 10.1038/s41418-019-0454-y. Epub 2019 Nov 12. Cell Death Differ. 2020. PMID: 31719651 Free PMC article. No abstract available.
28 results